Case analysis reveals severe hemolytic phenotype in children with sickle cell anemia and co-inherited red blood cell variants, indicating potential therapy implications.
Remarkable phenotypic variability exists among individuals with sickle cell anemia (SCA), which may be explained by co‐inheritance of traits affecting red blood cell (RBC) biology, such as genes affecting globin expression or glucose‐6‐phosphate dehydrogenase enzyme activity. Here, we describe three children with severe SCA who have co‐inherited variants in genes for membrane proteins ( SPTA1 and EPB1 ) and PIEZO1 . These cases suggest that variants in RBC membrane proteins may contribute to SCA severity and phenotypic variation. Co‐Inheritance of such variants could, in theory, affect outcomes of emerging SCA therapies, including genetic modification treatments.
No takes yet. Share an insight, caveat, or question.
Srinivas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: